The filing claims that Humana’s PBM levied unfair and unconscionable fees on AHF pharmacies in breach of the PBM’s contractual obligations and contrary to applicable law and regulations.

Express Scripts files suit against FTC, demands retraction of report on PBM industry These PBMs value high rebates ...

Humana declined to comment ... A growing chorus of patients, doctors and policymakers say PBM business practices are raising ...

In terms of liquidity and interest, the mean open interest for Humana options trades today is 270.0 with a total volume of ...

Express Scripts has filed a lawsuit against the Federal Trade Commission (FTC) over the agency's recent report on PBMs, which ...

The FTC has asked the six largest PBMs operating in the US market – CVS Caremark, Express Scripts, OptumRx, Humana ... methods to steer patients towards PBM-owned pharmacies, potentially ...

Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management. A Deep Dive into Humana's Financials ...

While probably not moatworthy on a stand-alone basis, in our opinion, Humana's ownership of the fourth-largest pharmacy benefit manager and its growing presence in the provider space help support ...

Humana (NYSE: HUM) currently trades around $355 per share, nearly 30% below its peak level of $495 seen in September 2022. In comparison, UnitedHealth stock (NYSE: UNH) saw its stock rise 13% over ...

Humana's stock dipped following the earnings report, prompting the organization to cut its earnings guidance for this year and next. Improving the Patient Financial Experience Throughout the Patient ...